HomeCompareJASBX vs JNJ

JASBX vs JNJ: Dividend Comparison 2026

JASBX yields 4.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JASBX wins by $6.2K in total portfolio value
10 years
JASBX
JASBX
● Live price
4.14%
Share price
$2.88
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$540.13
Full JASBX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JASBX vs JNJ

📍 JASBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJASBXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JASBX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JASBX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JASBX
Annual income on $10K today (after 15% tax)
$351.98/yr
After 10yr DRIP, annual income (after tax)
$459.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $244.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JASBX + JNJ for your $10,000?

JASBX: 50%JNJ: 50%
100% JNJ50/50100% JASBX
Portfolio after 10yr
$23.1K
Annual income
$683.96/yr
Blended yield
2.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JASBX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JASBX buys
0
JNJ buys
0
No recent congressional trades found for JASBX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJASBXJNJ
Forward yield4.14%3.36%
Annual dividend / share$0.12$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.2K$20.0K
Annual income after 10y$540.13$827.78
Total dividends collected$4.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JASBX vs JNJ ($10,000, DRIP)

YearJASBX PortfolioJASBX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,114$414.10$10,676$355.77+$438.00JASBX
2$12,322$430.12$11,407$389.39+$915.00JASBX
3$13,630$445.68$12,198$426.53+$1.4KJASBX
4$15,045$460.75$13,056$467.62+$2.0KJASBX
5$16,574$475.30$13,987$513.12+$2.6KJASBX
6$18,223$489.33$14,998$563.56+$3.2KJASBX
7$20,002$502.84$16,098$619.52+$3.9KJASBX
8$21,918$515.80$17,295$681.69+$4.6KJASBX
9$23,980$528.23$18,599$750.82+$5.4KJASBX
10$26,199$540.13$20,022$827.78+$6.2KJASBX

JASBX vs JNJ: Complete Analysis 2026

JASBXStock

The fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in short- and intermediate-term securities such as corporate bonds or notes or government securities, including agency securities. It may invest up to 35% of its net assets in high-yield/high-risk bonds, also known as "junk" bonds.

Full JASBX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JASBX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JASBX vs SCHDJASBX vs JEPIJASBX vs OJASBX vs KOJASBX vs MAINJASBX vs ABBVJASBX vs MRKJASBX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.